Stéphanie Boudon obtained a Pharmacy Doctorate (PharmD) at the University of Strasbourg, France, and a PhD in biological sciences (phototoxicity) at the University of Basel, Switzerland, in collaboration with Novartis Institute for BioMedical Research (NIBR, Basel), in PreClinical Safety. After a research position at DSM, she joined Bayer, where she was Senior Global Medical Affairs Manager for dermatology and gynecology. She joined SCAHT in 2021.